These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6358878)

  • 1. The induction of forward gene mutation and gene conversion in yeasts by treatment with cyclophosphamide in vitro and in vivo.
    Barale R; Rusciano D; Stretti G; Zucconi D; Monaco M; Mosesso P; Principe P
    Mutat Res; 1983 Nov; 111(3):295-312. PubMed ID: 6358878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenic relevance of rat hepatocyte nuclei in the activation and inactivation of xenobiotica. Cyclophosphamide and epichlorohydrin activity on the yeasts S. pombe and S. cerevisiae.
    Migliore L; Rossi AM; Loprieno N; Romano M; Salmona M
    Mutat Res; 1983 Nov; 111(3):313-23. PubMed ID: 6358879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organospecific activation of azathioprine in mice: role of liver metabolism in mutation induction.
    Hrelia P; Murelli L; Scotti M; Paolini M; Cantelli-Forti G
    Carcinogenesis; 1988 Jun; 9(6):1011-5. PubMed ID: 3286026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and biochemical investigation on chloral hydrate in vitro and in vivo.
    Bronzetti G; Galli A; Corsi C; Cundari E; Del Carratore R; Nieri R; Paolini M
    Mutat Res; 1984 Sep; 141(1):19-22. PubMed ID: 6384771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intrasanguineous host mediated assay procedure using Saccharomyces cerevisiae: comparison with two other metabolic activation systems.
    Frezza D; Smith B; Zeiger E
    Mutat Res; 1983 Mar; 108(1-3):161-8. PubMed ID: 6339885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
    Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
    Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic activation of promutagens in the yeast-microsome test. II. Activation of cyclophosphamide and 2-aminofluorene].
    Pavlov IuI; Khromov-Borisov NN
    Genetika; 1983 Mar; 19(3):362-74. PubMed ID: 6343182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic effects of procarbazine in the yeast Saccharomyces cerevisiae, strain D4.
    Frezza D; Bianchi V
    Teratog Carcinog Mutagen; 1984; 4(2):201-10. PubMed ID: 6145225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocytes-mediated metabolic activation of cyclophosphamide in yeast mutagenicity test.
    Corsi C; Paolini M; Galli A; Bronzetti G; Cantelli Forti G
    Teratog Carcinog Mutagen; 1985; 5(4):223-30. PubMed ID: 2866604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial mutation studies with tetrachlorvinphos (Gardona)).
    Brooks TM; Dean BJ; Hutson DH; Potter D
    Mutat Res; 1982 Oct; 105(4):211-21. PubMed ID: 6752704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The induction of mitotic gene conversion in the yeast, Saccharomyces cerevisiae JD1 by 4-chloromethylbiphenyl (4CMB), benzyl chloride (BC) and 4-hydroxymethylbiphenyl (4HMB).
    Brooks TM; Gonzalez LP
    Mutat Res; 1982; 100(1-4):157-62. PubMed ID: 7035886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of metabolic activation for four mutagens in a bacterial, fungal and two mammalian cell mutagenesis assays.
    Rees RW; Brice AJ; Carlton JB; Gilbert PJ; Mitchell ID
    Mutagenesis; 1989 Sep; 4(5):335-42. PubMed ID: 2687626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
    Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
    Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide: interstrain differences in the production of mutagenic metabolites by S9-fractions from liver and kidney in different mutagenicity test systems in vitro and in the teratogenic response in vivo between CBA and C 57 BL mice.
    Winckler K; Obe G; Madle S; Kocher-Becker U; Kocher W; Nau H
    Teratog Carcinog Mutagen; 1987; 7(4):399-409. PubMed ID: 2888218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of carcinogenic N-nitrosopropylamines to mutagens by lung and pancreas S9 fractions from various animal species and man.
    Mori Y; Yamazaki H; Toyoshi K; Maruyama H; Konishi Y
    Mutat Res; 1986 May; 160(3):159-69. PubMed ID: 3960034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activation of 3,3'-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450.
    Iba MM
    Mutat Res; 1987 Oct; 182(5):231-41. PubMed ID: 3309638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenic evaluation of the hair-dye component 2,4-diaminophenoxyethanol in Salmonella typhimurium/microsome plate test and Saccharomyces cerevisiae strains D4 and XV185-14C.
    Shahin MM; Bugaut A; Kalopissis G
    Mutat Res; 1982 Dec; 102(4):319-29. PubMed ID: 6757736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NADPH-generating system: influence on microsomal mono-oxygenase stability during incubation for the liver-microsomal assay with rat and mouse S9 fractions.
    Forti GC; Paolini M; Hrelia P; Corsi C; Biagi GL; Bronzetti G
    Mutat Res; 1984 Dec; 129(3):281-97. PubMed ID: 6392864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the optimal temperature for the liver microsomal assay with mice S9 fractions.
    Mannironi C; Cundari E; Bauer C; Del Carratore R; Bronzetti G; Corsi C; Nieri R; Paolini M
    Mutat Res; 1985 Oct; 147(5):231-5. PubMed ID: 3900710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of S9 and microsomal mix on activation of cyclophosphamide to induce genotoxicity in human lymphocytes.
    Kugler U; Bauchinger M; Schmid E; Göggelmann W
    Mutat Res; 1987 Mar; 187(3):151-6. PubMed ID: 3821768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.